January/February leadership message

Published:October 12, 2022DOI:
      The annual death rate from myocardial infarction has decreased significantly over the last several years (from 257 deaths per 1000,000 population in 2000 to 161.5 deaths per 100,000 in 2019)

      Sawyer A & Flagg LA. State decline in heart disease mortality in the United States, 2000-2019. Accessed September 19, 2022.

      due to both primary and secondary prevention strategies and early intervention to re-open coronary arteries. Despite this encouraging news, heart disease remains the leading cause of death for both men and women in the United States, much of it attributed to death from heart failure.

      Heart Disease Facts. Accessed September 19, 2022.

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart & Lung: The Journal of Cardiopulmonary and Acute Care
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Sawyer A & Flagg LA. State decline in heart disease mortality in the United States, 2000-2019. Accessed September 19, 2022.

      2. Heart Disease Facts. Accessed September 19, 2022.

      3. Facts about heart failure in the United States. Accessed September 15, 2022.

        • Mozaffarian D
        • Benjamin EJ
        • Go AS
        • et al.
        American Heart Association statistics committee; stroke statistics subcommittee. Heart disease and stroke statistics-2016 update: a report from the American Heart Association.
        Circulation. 2016; 133: e38-e360
        • Heidenreich PA
        • Bozkurt B
        • Aguilar D
        • Allen LA
        • et al.
        2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines.
        JACC. 2022; 79: e263-e421


      Maureen Flattery, RN, MS, ANP has been involved with the heart failure/transplant program at Virginia Commonwealth University since 1992, as a coordinator and later as a nurse practitioner and program manager. She is currently the interim Director of Transplant Clinical Services. She has co-authored several papers on heart failure, heart transplantation and MCS and presented at both national and local conferences. She has been a member of AAHFN since its inception and served as newsletter editor, Publications Committee and Annual Meeting Committee chair and has contributed to several AAHFN publications. She received her BSN from Niagara University and MS from Virginia Commonwealth University.